Black Rock Inc. Harvard Bioscience Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,833,664 shares of HBIO stock, worth $8.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,833,664

Previous 2,913,814 2.75%

Holding current value

$8.08 Million

Previous $15.6 Million 22.93%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.02 - $5.39 $322,202 - $432,008	-80,150 Reduced 2.75%	2,833,664 $12 Million
Q4 2023 Feb 13, 2024	BUY	$4.0 - $5.49 $684,548 - $939,542	171,137 Added 6.24%	2,913,814 $15.6 Million
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $475,704 - $692,149	118,926 Added 4.53%	2,742,677 $11.8 Million
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $7.2 Million - $10.6 Million	1,719,006 Added 190.0%	2,623,751 $14.4 Million
Q1 2023 May 12, 2023	BUY	$2.45 - $4.22 $1,639 - $2,823	669 Added 0.07%	904,745 $3.8 Million

Q4 2022 Feb 13, 2023	SELL	$2.12 - $2.86 $612,726 - $826,602	-289,022 Reduced 24.22%	904,076 $2.5 Million
Q3 2022 Nov 14, 2022	SELL	$2.58 - $3.92 $41,334 - $62,802	-16,021 Reduced 1.33%	1,193,098 $3.05 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $6.06 Million - $11.9 Million	-1,848,883 Reduced 60.46%	1,209,119 $4.35 Million
Q1 2022 May 12, 2022	SELL	$5.16 - $7.14 $26,770 - $37,042	-5,188 Reduced 0.17%	3,058,002 $19 Million
Q4 2021 Feb 10, 2022	BUY	$6.37 - $8.18 $2.07 Million - $2.66 Million	325,723 Added 11.9%	3,063,190 $21.6 Million
Q3 2021 Nov 09, 2021	BUY	$6.98 - $8.47 $42,180 - $51,184	6,043 Added 0.22%	2,737,467 $19.1 Million
Q2 2021 Aug 11, 2021	BUY	$5.44 - $8.4 $14.9 Million - $22.9 Million	2,731,424 New	2,731,424 $22.8 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

32.8M

Call Options Held

Put Options Held

2.2K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $119M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account